131 related articles for article (PubMed ID: 29467239)
1. Frequency and consequence of the recurrent
Parekh VI; Modali SD; Welch J; Simonds WF; Weinstein LS; Kebebew E; Agarwal SK
Endocr Relat Cancer; 2018 May; 25(5):L31-L35. PubMed ID: 29467239
[No Abstract] [Full Text] [Related]
2. Whole exome sequencing of insulinoma reveals recurrent T372R mutations in YY1.
Cao Y; Gao Z; Li L; Jiang X; Shan A; Cai J; Peng Y; Li Y; Jiang X; Huang X; Wang J; Wei Q; Qin G; Zhao J; Jin X; Liu L; Li Y; Wang W; Wang J; Ning G
Nat Commun; 2013; 4():2810. PubMed ID: 24326773
[TBL] [Abstract][Full Text] [Related]
3. Frequency and clinical correlates of somatic Ying Yang 1 mutations in sporadic insulinomas.
Lichtenauer UD; Di Dalmazi G; Slater EP; Wieland T; Kuebart A; Schmittfull A; Schwarzmayr T; Diener S; Wiese D; Thasler WE; Reincke M; Meitinger T; Schott M; Fassnacht M; Bartsch DK; Strom TM; Beuschlein F
J Clin Endocrinol Metab; 2015 May; 100(5):E776-82. PubMed ID: 25763608
[TBL] [Abstract][Full Text] [Related]
4. T372R Mutation Status in Yin Yang 1 Gene in Insulinoma Patients.
Irshad K; Jyotsna VP; Agarwal S; Chosdol K; Pal S; Deepak RK
Horm Metab Res; 2017 Jun; 49(6):452-456. PubMed ID: 28472826
[TBL] [Abstract][Full Text] [Related]
5. Neomorphic effects of recurrent somatic mutations in Yin Yang 1 in insulin-producing adenomas.
Cromer MK; Choi M; Nelson-Williams C; Fonseca AL; Kunstman JW; Korah RM; Overton JD; Mane S; Kenney B; Malchoff CD; Stalberg P; Akerström G; Westin G; Hellman P; Carling T; Björklund P; Lifton RP
Proc Natl Acad Sci U S A; 2015 Mar; 112(13):4062-7. PubMed ID: 25787250
[TBL] [Abstract][Full Text] [Related]
6. Neuroendocrine cancer: Insulinomas-recurrent mutations identified in YY1.
Greenhill C
Nat Rev Endocrinol; 2014 Mar; 10(3):127. PubMed ID: 24366121
[No Abstract] [Full Text] [Related]
7. Mutation Status in Yin Yang 1 Gene in X-ray-Induced Insulinoma Cell Line Rin-5F.
Kiba T
Pancreas; 2020 Jul; 49(6):e49-e50. PubMed ID: 32590621
[No Abstract] [Full Text] [Related]
8. [Expression of YY 1 protein in human insulinoma and its clinical implication].
Li WX; Huang YE; Shi XX; Lin PX; Zhou ZN; Zhang YZ; Shen H
Nan Fang Yi Ke Da Xue Xue Bao; 2016 Mar; 36(3):361-4. PubMed ID: 27063163
[TBL] [Abstract][Full Text] [Related]
9. Significance of the pathogenic mutation T372R in the Yin Yang 1 protein interaction with DNA--thermodynamic studies.
Nieborak A; Górecki A
FEBS Lett; 2016 Mar; 590(6):838-47. PubMed ID: 26910132
[TBL] [Abstract][Full Text] [Related]
10. Mutation and Expression of Gene YY1 in Pancreatic Neuroendocrine Tumors and Its Clinical Significance.
Song YL; Xu J; Zhao DC; Zhang TP; Jin KZ; Zhu LM; Yu S; Chen YJ
Endocr Pract; 2021 Sep; 27(9):874-880. PubMed ID: 33705973
[TBL] [Abstract][Full Text] [Related]
11. Clinical implications of microsatellite instability and MLH1 gene inactivation in sporadic insulinomas.
Mei M; Deng D; Liu TH; Sang XT; Lu X; Xiang HD; Zhou J; Wu H; Yang Y; Chen J; Lu CM; Chen YJ
J Clin Endocrinol Metab; 2009 Sep; 94(9):3448-57. PubMed ID: 19567531
[TBL] [Abstract][Full Text] [Related]
12. High frequency of down-regulation of E-cadherin detected in benign sporadic insulinomas by multiplex ligation-dependent probe amplification.
Jia H; Jiang X; Zhao Z; Ge Y; Lu J; Zhao Y; Cui B; Ning G
Hum Pathol; 2009 Sep; 40(9):1336-41. PubMed ID: 19427668
[TBL] [Abstract][Full Text] [Related]
13. Chromosome 1q loss of heterozygosity frequently occurs in sporadic insulinomas and is associated with tumor malignancy.
Yang YM; Liu TH; Chen YJ; Jiang WJ; Qian JM; Lu X; Gao J; Wu SF; Sang XT; Chen J
Int J Cancer; 2005 Nov; 117(2):234-40. PubMed ID: 15900598
[TBL] [Abstract][Full Text] [Related]
14. Aggressive versus indolent insulinomas: new clinicopathological insights.
Hackeng WM; Brosens LAA; Dreijerink KMA
Endocr Relat Cancer; 2023 May; 30(5):. PubMed ID: 36779771
[TBL] [Abstract][Full Text] [Related]
15. Histologic and Molecular Profile of Pediatric Insulinomas: Evidence of a Paternal Parent-of-Origin Effect.
Bhatti TR; Ganapathy K; Huppmann AR; Conlin L; Boodhansingh KE; MacMullen C; Becker S; Ernst LM; Adzick NS; Ruchelli ED; Ganguly A; Stanley CA
J Clin Endocrinol Metab; 2016 Mar; 101(3):914-22. PubMed ID: 26756113
[TBL] [Abstract][Full Text] [Related]
16. Chromosomal instability predicts metastatic disease in patients with insulinomas.
Jonkers YM; Claessen SM; Perren A; Schmid S; Komminoth P; Verhofstad AA; Hofland LJ; de Krijger RR; Slootweg PJ; Ramaekers FC; Speel EJ
Endocr Relat Cancer; 2005 Jun; 12(2):435-47. PubMed ID: 15947114
[TBL] [Abstract][Full Text] [Related]
17. Insulinomatosis: a multicentric insulinoma disease that frequently causes early recurrent hyperinsulinemic hypoglycemia.
Anlauf M; Bauersfeld J; Raffel A; Koch CA; Henopp T; Alkatout I; Schmitt A; Weber A; Kruse ML; Braunstein S; Kaserer K; Brauckhoff M; Dralle H; Moch H; Heitz PU; Komminoth P; Knoefel WT; Perren A; Klöppel G
Am J Surg Pathol; 2009 Mar; 33(3):339-46. PubMed ID: 19011561
[TBL] [Abstract][Full Text] [Related]
18. Molecular genetics of malignant insulinoma.
Pavelic K; Hrascan R; Kapitanovic S; Vranes Z; Cabrijan T; Spaventi S; Korsic M; Krizanac S; Li YQ; Stambrook P; Gluckman JL; Pavelic ZP
Anticancer Res; 1996; 16(4A):1707-17. PubMed ID: 8712689
[TBL] [Abstract][Full Text] [Related]
19. Somatic mutations of the MEN1 tumor suppressor gene in sporadic gastrinomas and insulinomas.
Zhuang Z; Vortmeyer AO; Pack S; Huang S; Pham TA; Wang C; Park WS; Agarwal SK; Debelenko LV; Kester M; Guru SC; Manickam P; Olufemi SE; Yu F; Heppner C; Crabtree JS; Skarulis MC; Venzon DJ; Emmert-Buck MR; Spiegel AM; Chandrasekharappa SC; Collins FS; Burns AL; Marx SJ; Lubensky IA
Cancer Res; 1997 Nov; 57(21):4682-6. PubMed ID: 9354421
[TBL] [Abstract][Full Text] [Related]
20. Expression and functional consequences of oestrogen and progesterone receptors in human insulinomas.
Alabraba EB; Taniere P; Reynolds GM; Stewart PM; Wigmore SJ; Bramhall SR
Endocr Relat Cancer; 2007 Dec; 14(4):1081-8. PubMed ID: 18045959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
